News Chart Pasithea Therapeutics Corp.

Equities

KTTA

US70261F2020

Real-time Estimate Cboe BZX Other stock markets 08:12:07 15/05/2024 pm IST			5-day change	1st Jan Change
6.8 ^USD	+2.26%		-6.47%	-10.14%

24/04	Pasithea Therapeutics Corp. Announces the First Cohort Has Completed the Initial Dosing in Its Phase 1 Trial Evaluating Pas-004 in Ras, Nf1 and Raf Mutated Cancers	CI
29/03	Pasithea Therapeutics Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

c28d79dae31d62edce459fef3.-BsLcnl9Z729rkTD4LqmOooMcyD22xKmDw-OSkBcOH4.iHdiFBhFKvSF4zfxqPHyaNpaRHeUjn_nZVjUEzpkdRa6TEkrNBYjjdb9DQ~61a9f9235b1873e20006045228da9111